WHO ICTRP trial
Zacras Combination Tablets LD & HD specified drug-use survey "Long-term use…
JPRN-jRCT1080222541 · Japan Primary Registries Network (JPRN)
Key facts
| Trial ID | JPRN-jRCT1080222541 |
|---|---|
| Public title | Zacras Combination Tablets LD & HD specified drug-use survey "Long-term use survey" |
| Scientific title | Zacras Combination Tablets LD & HD specified drug-use survey "Long-term use survey" |
| Primary sponsor | TAKEDA PHARMACEUTICAL COMPANY LTD. |
| Registry | Japan Primary Registries Network (JPRN) |
| Study type | Observational |
| Conditions | Hypertension |
| Interventions | investigational material(s) Generic name etc : Zacras Combination Tablets LD & HD (azilsartan/amlodipine) INN of investigational material : Therapeutic category code : 214 Antihypertensives Dosage and Administration for Investigational… |
| Registration date | Jun 25, 2014 |
| Target size | 1090 |
| Secondary IDs | JapicCTI-142592 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: